SLC25A13 and glioblastoma: We queried the cBioPortal database [42,43] to determine whether the expression of NAGS, CPS1, and citrin in glioblastoma multiforme, glioma, stomach adenocarcinoma, and lung adenocarcinoma correlated with the patient outcomes for these four tumor types.